The effect of financial and educational incentives on rational prescribing: A state-space approachPechlivanoglou, P., Wieringa, J. E., de Jager, T. & Postma, M. J., Apr-2015, In : Health Economics. 24, 4, p. 439-453 15 p.
Research output: Contribution to journal › Article › Academic › peer-review
In 2005, a Dutch health insurer introduced a financial incentive directed to general practitioners to promote rational prescribing of statins and proton pump inhibitors (PPIs). Concomitantly, a regional institution that develops pharmacotherapeutic guidelines implemented two educational interventions also aiming at promoting rational statin and PPI prescribing. Utilizing a prescription database, we estimated the effect of the interventions on drug utilization and cost of statins and PPIs over time. We measured the effect of the interventions within an implementation and a control region. The implementation region included prescriptions from the province of Groningen where the educational intervention was implemented and where the health insurer is most active. The control region comprised all other provinces covered by the database. We modelled the effect of the intervention using a state-space approach. Significant differences in prescribing and cost patterns between regions were observed for statins and PPIs. These differences however were mostly related to the concurrent interventions of Proeftuin Farmacie Groningen. We found no evidence indicating a significant effect of the rational prescribing intervention on the prescription patterns of statins and PPIs. Our estimates on the economic impact of the Proeftuin Farmacie Groningen interventions indicate that educational activities as such can achieve significant cost savings. Copyright © 2014 John Wiley & Sons, Ltd.
|Number of pages||15|
|Early online date||11-Feb-2014|
|Publication status||Published - Apr-2015|
- Drug prescribing, Financial incentives , Health insurers , Kalman filter , State space , The Netherlands , Time Series, hydroxymethylglutaryl coenzyme A reductase inhibitor, statin (protein), proton plump inhibitor, health, Netherlands, time series analysis, prescription, data base, human, cost control, son, general practitioner, drug utilization